The HTG EdgeSeq Oncology Biomarker Panel (OBP) is a systems biology pathway analysis tool that profiles samples to identify therapeutic targets and drug response markers. The OBP assay utilizes our automated HTG EdgeSeq system coupled with the sensitivity and dynamic range of next-generation sequencing (NGS)-based detection, and can be performed in your lab using the HTG EdgeSeq system.
Breast Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer
AKT1 (V-akt murine thymoma viral oncogene homolog 1), CD19 (CD19 Molecule), CTLA4 (Cytotoxic T-Lymphocyte Associated Protein 4), EGFR (Epidermal growth factor receptor), ERBB3 (V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 3), FGFR1 (Fibroblast growth factor receptor 1)
See More ...
Next-Generation Sequencing (NGS)